Sionna eyes up $156M IPO to fund cystic fibrosis trials

cafead

Administrator
Staff member
  • cafead   Feb 03, 2025 at 11:52: AM
via Sionna Therapeutics is eyeing a $156 million IPO as the cystic-fibrosis-focused biotech looks to take its lead candidate into phase 2.

article source